A0A097J809 (A0A097J809_BPT4) Enterobacteria phage RB59

Endolysin UniProtKBAFDB90v4InterProInteractive Modelling

164 aa; Sequence (Fasta) ; 3 identical sequences: Enterobacteria phage RB55: A0A097J792; Escherichia phage T4: A0A7S9SVX7; Enterobacteria phage T4: D9IEF7

Available Structures

71 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
The cryoEM structure of human gamma-Secretase complex Heteromer
D9IEF7; P49768; Q92542;
1-162
Assess
Crystal structure of the Ca2+-free T4L-MICU1-MICU2 complex Heteromer
D9IEF7; Q8IYU8; Q9BPX6;
1-161
Assess
Muscarinic acetylcholine receptor 1 - muscarinic toxin 7 complex Heteromer
D9IEF7; P11229; Q8QGR0;
2-161
ACM;Y01;OIN;
Assess
Structure of human beta1 adrenergic receptor bound to BI-167107 and nanobody 6B9 Heteromer
D9IEF7; P08588;
2-161
GLC;SO4;CLR;1WV;NA;EPE;P0G;P6G;
Assess
Structure of human beta1 adrenergic receptor bound to norepinephrine and nanobody 6B9 Heteromer
D9IEF7; P08588;
2-161
GLC;E5E;SO4;NA;EPE;480;CLR;PG4;
Assess
Structure of human beta1 adrenergic receptor bound to epinephrine and nanobody 6B9 Heteromer
D9IEF7; P08588;
2-161
ALE;SO4;NA;EPE;CLR;1WV;
Assess
Mechanism of Phosphate Sensing and Signaling Revealed by Rice SPX1-PHR2 Complex Structure Heteromer
D9IEF7; Q69XJ0; Q6Z156;
3-161
IHP;
Assess
Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist Heteromer
D9IEF7; P21728; P59768; P62873; P63092;
3-161
VFP;1PE;
Assess
Structure of drosophila STING in complex with 3'2'-cGAMPhomo-2-mer1-164
4UR;
Assess
T4 lysozyme mutant-S44C/C54T/N68C/A93C/C97A/T115C, pH10monomer1-164
GOL;HEZ;
Assess
T4 lysozyme mutant-S44C/C54T/N68C/A93C/C97A/T115C, pH7monomer1-164
HEZ;GOL;NA;
Assess
T4 lysozyme with a 2,6-diazaadamantane nitroxide (DZD) spin labelmonomer1-164
BME;X8R;K;CL;
Assess
T4 lysozyme mutant-S44C/C54T/N68C/A93C/C97A/T115C, pH4monomer1-164
GOL;HEZ;PO4;NA;
Assess
Structure of DCN1 bound to N-((4S,5S)-7-ethyl-4-(4-fluorophenyl)-3-methyl-6-oxo-1-phenyl-4,5,6,7-te…monomer1-164
MPD;O37;
Assess
Spin-labeled T4 Lysozyme (9/131FnbY)-(4-Amino-TEMPO)monomer1-164
QPM;
Assess
Structure of DCN1 bound to N-((4S,5S)-3-(aminomethyl)-7-ethyl-4-(4-fluorophenyl)-6-oxo-1-phenyl-4,5…monomer1-164
YHP;
Assess
Structure of DCN1 bound to 3-methyl-N-((4S,5S)-3-methyl-6-oxo-1-phenyl-4-(p-tolyl)-4,5,6,7-tetrahyd…monomer1-164
O0A;
Assess
Structure of Spin-labelled T4 lysozyme mutant L115C-R119C-R1 at room temperaturemonomer1-164
Assess
Structure of the drosophila STING cyclic dinucleotide binding domainmonomer1-164
Assess
CRYSTAL STRUCTURE OF T4 LYSOZYME-GSS-PEPTIDE IN COMPLEX WITH TEICOPLANIN-A2-2monomer1-164
GCS;T55;NAG;MAN;PO4;GOL;
Assess
MTSL labelled T4 lysozyme pseudo-wild type V75C mutantmonomer1-164
MTN;CL;
Assess
DCN1 bound to DI-1859monomer1-164
H8S;
Assess
DCN1 bound to inhibitor 10monomer1-164
H9P;
Assess
DCN1 covalently bound to inhibitor 4monomer1-164
H9S;
Assess
CRYSTAL STRUCTURE OF T4 LYSOZYME-PEPTIDE IN COMPLEX WITH TEICOPLANIN-A2-2monomer1-164
GCS;NAG;MAN;T55;CL;NA;PO4;GOL;
Assess
DCN1 bound to DI-1548monomer1-164
H8S;
Assess
Neutron crystal structure of T4L M6AEmonomer1-164
Assess
T4 lysozyme mutant-S44C/C54T/N68C/A93C/C97A/T115C, DMSO 40%, and then backsoakingmonomer1-163
GOL;NA;CL;
Assess
DCN1 bound to 8monomer2-164
EDO;H8V;
Assess
PI4K IIalpha bound to calciummonomer2-164
ATP;CA;
Assess
Crystal structure of phosphatidyl inositol 4-kinase II alpha in complex with nucleotide analogmonomer2-164
M59;ADP;
Assess
Crystal structure of phosphatidyl inositol 4-kinase II alpha in complex with ATPmonomer2-164
ATP;
Assess
DCN1 bound to inhibitor 9monomer2-164
H9M;
Assess
T4 lysozyme mutant-S44C/C54T/N68C/A93C/C97A/T115C, DMSO 20%monomer1-162
GOL;DMS;HEZ;NA;CL;
Assess
T4 lysozyme pseudo-wild type soaked in TEMPOLmonomer1-162
CL;HED;PO4;
Assess
T4 lysozyme pseudo-wild type soaked in TEMPOmonomer1-162
CL;HED;
Assess
MTSL labelled T4 lysozyme pseudo-wild type K65C mutantmonomer1-162
CL;MTN;HED;
Assess
The crystal structure of Neisseria gonorrhoeae DolP (NGO1985)monomer1-162
CL;
Assess
T4 lysozyme mutant L99A in complex with 3-butylpyridinemonomer2-162
Y8J;BME;TRS;
Assess
T4 lysozyme mutant L99Amonomer2-162
YGS;BME;TRS;
Assess
Crystal Structure of human mARC1 A165T Variantmonomer1-161
EFK;MTE;B3P;CL;
Assess
Crystal structure of the N-terminal domain of the human mitochondrial calcium uniporter fused with …monomer1-161
SO4;
Assess
XFEL beta2 AR structure by ligand exchange from Timolol to Alprenolol.monomer2-162
JTZ;CLR;OLB;OLC;SO4;OLA;
Assess
XFEL beta2 AR structure by ligand exchange from Timolol to Carvedilol.monomer2-162
CVD;SO4;CLR;OLC;OLA;
Assess
Crystal structure of the N-terminal domain single mutant (S92E) of the human mitochondrial calcium …monomer1-161
SO4;
Assess
XFEL beta2 AR structure by ligand exchange from Timolol to ICI-118551.monomer2-162
JRZ;SO4;CLR;OLA; 10×OLC;
Assess
XFEL beta2 AR structure by ligand exchange from Timolol to Timolol.monomer2-162
TIM;SO4;CLR;OLC;OLA;
Assess
Crystal structure of the N-terminal domain single mutant (S92A) of the human mitochondrial calcium …monomer1-161
SO4;
Assess
XFEL beta2 AR structure by ligand exchange from Alprenolol to Alprenolol.monomer2-162
JTZ;CLR;OLC;OLA;SO4;
Assess
Crystal structure of the N-terminal domain single mutant (D119A) of the human mitochondrial calcium…monomer1-161
SO4;
Assess
XFEL beta2 AR structure by ligand exchange from Timolol to Propranolol.monomer2-162
SNP;SO4;CLR;OLA;OLC;
Assess
Haloperidol bound D2 dopamine receptor structure inspired discovery of subtype selective ligandsmonomer2-162
GMJ;OLA;
Assess
The beta2 adrenergic receptor bound to a negative allosteric modulatormonomer2-162
CLR;JTZ;M3J;
Assess
XFEL beta2 AR structure by ligand exchange from Alprenolol to Timolol.monomer2-162
TIM;SO4;CLR;OLC;OLA;
Assess
XFEL beta2 AR structure by ligand exchange from Alprenolol to Carazolol.monomer2-162
CAU;SO4;CLR;OLC;OLA;
Assess
Crystal structure of A2AR-T4L in complex with 2-118monomer2-161
VBF;CLR; 18×OLA;NA;OLC;
Assess
Crystal structure of A2AR-T4L in complex with AB928monomer2-161
18×OLA;NA;OLC;U30;PEG;CLR;
Assess
Structure of human beta1 adrenergic receptor bound to carazololmonomer2-161
CLR;CAU;SO4;1WV;NA;CIT;PG4;
Assess
Structure of the M5 muscarinic acetylcholine receptor (M5-T4L) bound to tiotropiummonomer2-161
OLA;0HK;P33;OLC;
Assess
Crystal structure of mycolic acid transporter MmpL3 from Mycobacterium smegmatis complexed with SQ1…monomer2-161
3RX;LMT;MHA;
Assess
Crystal structure of mycolic acid transporter MmpL3 from Mycobacterium smegmatismonomer2-161
MHA;L6T;
Assess
Crystal structure of mycolic acid transporter MmpL3 from Mycobacterium smegmatis complexed with ICA…monomer2-161
MHA;L6T;J9E;
Assess
Crystal structure of human G protein coupled receptormonomer2-161
9JU;OLA;OLC;PEG;EPE;PG4;SO4;
Assess
Crystal structure of mycolic acid transporter MmpL3 from Mycobacterium smegmatis complexed with AU1…monomer2-161
9ZF;L6T;MHA;
Assess
Crystal structure of mycolic acid transporter MmpL3 from Mycobacterium smegmatis complexed with Rim…monomer2-161
AY6;L6T;MHA;
Assess
Structure of beta2 adrenergic receptor fused to a Gs peptidemonomer2-161
P0G;
Assess
Leukotriene B4 receptor BLT1 in complex with BIIL260monomer2-161
7Y9;
Assess
X-ray structure of yeast dynein motor domain in the presence of a pyrazolo-pyrimidinone-based compo…monomer4-161
Assess
XFEL crystal structure of the prostaglandin D2 receptor CRTH2 in complex with 15R-methyl-PGD2monomer61-161
YSS;NA;FLC;SO4;
Assess
M3-mT4L receptor bound to tiotropiummonomer61-161
0HK;P6G;TAR;
Assess
M3-mT4L receptor bound to NMSmonomer61-161
TAR;3C0;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1t6h.1.Amonomer0.891-164
100.00
Assess